Loading clinical trials...
Loading clinical trials...
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of FX006 in Patients With Hip Osteoarthritis
Conditions
Interventions
FX006
Normal saline
Locations
32
United States
Arizona Research Center
Phoenix, Arizona, United States
Noble Clinical Research
Tucson, Arizona, United States
Hope Clinical Research
Canoga Park, California, United States
TriWest Research Associates, LLC
El Cajon, California, United States
BioSolutions Clinical Research Center
La Mesa, California, United States
Artemis Institute for Clinical Research
San Diego, California, United States
Start Date
December 12, 2018
Primary Completion Date
August 7, 2019
Completion Date
August 7, 2019
Last Updated
January 24, 2024
NCT05357378
NCT05700682
NCT06342843
NCT05169229
NCT06088160
NCT06578182
Lead Sponsor
Pacira Pharmaceuticals, Inc
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions